Grupo Cibest S.A.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Net income $4.4b
$1.9b -56.59%
$3.4b +81.93%
($1.6b) -147.57%
$2.8b +270.63%
$9.4b +237.58%
$7.9b -16.78%
$6.2t +78960.23%
$6.4t +2.42%
$3.9t -38.08%
$3.7t -7.08%
Net changes in investment securities recognized at fair value through profit or loss ($2.0t) ($8.4t) ($3.0t)
Depreciation and amortization $1.4b $1.5b $1.1b $1.1b $1.5b $1.2b $1.1b $1.1t $1.0t $1.1t $1.0t
Other assets impairment $42.0b $106.4b $58.0b
(Recovery) / impairment of investments in subsidiaries, associates and joint ventures $108.2b $314.3b ($117.9b)
Impairment of goodwill $0 $0 $3.5t
Credit impairment charges on loans and advances and financial leases $7.5t $5.4t $4.6t
Credit impairment charges on off balance sheet credit and other financial instruments $107.0m $38.7b ($29.6b)
Equity method ($113.1b) ($222.6b) ($349.0b)
Decrease / (increase) in accounts receivable ($209.5m) ($1.2b) ($1.1b) $515.7m ($795.7m) ($1.8b) ($440.4m) ($525.5b) ($713.1b) $1.2t
Decrease (Increase) in Related parties’ receivables ($172.3m) ($41.3m) $17.5m ($58.5m) $98.9m ($78.9m) ($69.5m) ($68.2m) ($102.4m)
Proceeds from sales of assets held for sale and inventories $1.1t $1.4t $1.5t
Decrease (Increase) in Inventory ($84.9m) ($887.6m) ($1.1b) $1.8b ($777.4m) ($2.7b) ($1.5b) $1.6b $357.6m
Increase / (decrease) in accounts payable ($372.4m) $1.2b $460.4m ($152.0m) $1.1b $836.4m $2.4b $945.9b ($859.4b) $742.0b $1.7t
Increase (Decrease) in Related parties’ payables ($36.1m) $39.6m $90.8m ($93.1m) ($113.2m) ($38.6m) ($8.5m) $62.8m $685.1m
Increase (Decrease) in Accounts payable other and accrued liabilities and taxes other than income taxes $410.1m $800.1m $929.8m $484.1m ($404.1m) ($2.8b) ($3.8b) ($2.0b) ($2.3b) $1.7t
(Increase) / decrease in other assets ($1.2t) $895.9b ($1.2t)
Increase / (decrease) in other liabilities $245.6b ($1.4t) $409.4b
Investment property valuation ($197.5b) ($200.3b) ($109.8b)
Purchases of premises and equipment and investment properties ($3.1b) ($3.0b) ($2.0b) ($1.3b) ($951.2m) ($1.1b) ($1.7b) ($2.4t) ($2.0t) ($2.2t)
Proceeds from sales of premises and equipment and investment properties $185.3b $414.0b $496.1b
Net cash used in investing activities ($5.4b) ($3.1b) ($820.2m) ($106.7m) ($832.7m) ($1.0b) ($4.1b) ($159.7b) ($559.2b) ($2.2t) ($3.6t)
Net Cash from Investing Activities ($54.1m) $339.5m $88.9m
Purchases of debt instruments at amortized cost ($3.6t) ($2.1t) ($2.0t)
Proceeds from maturities of debt instruments at amortized cost $4.7t $1.6t $1.1t
Purchases of debt instruments at fair value through OCI ($7.8t) ($448.9b) ($436.3b)
Proceeds from debt instruments at fair value through OCI $9.3t $2.3t $1.0t
Increase in repurchase agreements and other similar secured borrowing $304.8b $550.6b $34.0b
Proceeds from borrowings from other financial institutions $9.9t $9.4t $7.5t
Repayment of borrowings from other financial institutions ($9.9t) ($10.5t) ($10.8t)
Placement of debt instruments in issue $1.8t $4.2t $2.5t
Payment of debt instruments in issue ($3.9t) ($9.3t) ($1.6t)
Repurchase and placement of own capital stocks, net $938.3m ($278.9m) ($1.6b) ($156.1m) ($42.0m) ($74.5m) ($90.1m) ($89.0m) ($126.5m)
Dividends ($127.4b) ($140.6b) ($154.4b) ($4.3t)
Dividend received $155.7b $223.3b $237.3b $216.3b
Dividends paid ($2.0b) ($3.3t) ($3.4t) ($5.2t) ($4.3t)
Net cash (used) provided in financing activities(4) $898.1m
($374.3m) -141.68%
($2.6b) -605.71%
($211.1m) +92.01%
($2.1b) -888.00%
($161.9m) +92.24%
$2.2b +1480.11%
($5.4t) -243084.94%
($9.2t) -70.23%
($8.2t) +10.79%
Increase / (decrease) in cash and cash equivalents $1.2b ($308.3m) ($237.7m) $725.0m $715.5m $7.2b $7.0b $13.6t ($9.4t) $1.8t
Cash and cash equivalents at beginning of year $31.6t $39.8t $32.8t $33.4t $28.3t
Effect of exchange rate changes ($245.9b) $307.7b ($1.1t) ($432.3b)
Effect of exchange rate changes on cash and cash equivalents $151.1m ($24.6m) $21.3m ($265.8m) ($434.2m) $186.8m ($630.2m) ($5.4t) $2.4t ($1.2t) ($432.3b)
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Gain on sales of assets ($170.9b) ($103.5b) ($238.3b)
Valuation gain on investment securities ($1.7t) ($2.4t) ($2.5t)
Gain upon disposal of investment in subsidiaries, associates, and joint ventures $0 $0 ($11.5b)
Valuation on derivative financial instruments ($180.2b) ($323.8b) $62.5b
Income tax $936.4m $1.1b $752.5m $3.3b $2.1b $4.4b $3.3b $1.9t $2.4t $2.9t
Bonuses and short-term benefits $6.4m ($8.0m) ($10.1m) $41.6m $12.1m $979k $6.5m $734.9b $811.6b $1.0t
Other non-cash items $74.9b ($10.3b) ($41.4b)
Net interest ($140.0m) ($252.3m) ($312.8m) ($146.0m) ($107.8m) ($65.9m) ($445.9m) ($18.6t) ($17.6t) ($18.0t)
Decrease / (increase) in derivative financial instruments $860.0b ($394.6b) $290.1b
Increase in loans and advances to customers ($10.6t) ($21.6t) ($27.3t)
Increase in deposits by customers $17.0t $18.3t $28.0t
Increase / (decrease) in estimated liabilities and provisions ($40.6b) ($18.2b) $8.5b
Recovery of charged-off loans $770.9b $926.3b $865.9b
Income tax paid ($4.2b) ($1.7b) ($31.2m) ($204.5m) ($2.7t) ($2.0t) ($2.4t)
Interest received $34.7t $33.2t $31.8t $32.0t
Interest paid ($16.0t) ($15.0t) ($13.3t) ($13.4t)
Purchases of equity instruments at fair value through OCI and interests in associates and joint ventures ($122.9b) ($134.4b) ($21.5b)
Proceeds from equity instruments at fair value through OCI and interests in associates and joint ventures $16.8b $40.5b $77.3b
Purchase of other long-term assets ($351.5b) ($203.1b) ($275.1b)
Payment of lease liability ($182.6b) ($174.8b) ($203.4b)
Buyback of shares $0 $0 ($431.4b)
Transactions with non-controlling interests ($41.2b) ($19.5b) ($18.1b)
(Gain) Loss in financial instruments $0 $778.6m ($64.4m) ($68.1m)
Interest expense from financing activities $40.2m $54.4m $16.5m $55.0m $53.7m $87.4m $56.4m $153.7m $3.7m
Total Adjustments $6.8b $4.2b $5.0b $2.7b $6.3b $15.0b $12.7b $6.2b $11.9b
Decrease (increase) in other non-current assets ($119.5m) ($60.1m) $159.7m ($52.3m) $10.7m ($9.2m) ($32.8m) $301.9m $162.3m
Acquisition of other equity instruments $0 ($2.1b) ($88.6m) $0
Gain (Loss) on financial instruments $0 ($778.6m) $64.4m $68.1m
Interest income collected $108.2m $54.2m $102.3m $146.0m $107.8m $65.9m $445.9m $931.9m $1.6b
Loan from related parties $0 $2.4b $0 $0
Cash and cash equivalents at end of year $7.5b $7.5b $7.0b $7.0b $7.7b $15.1b $21.5b $23.6b $29.2b $33.5t
Loss on financial instruments ($778.6m)
Allowance for doubtful accounts ($16.5m) $5.3m $27.9m $5.3m $0
Unrealized foreign exchange loss (gain), net $169.7m ($35.8m) ($7.0m) $18.0m $0
Collection of loans to related parties $1.9b $1.1b
Cash paid for Business acquisition, net ($639.0m)
Loans granted to related parties ($2.3b) ($412.4m) ($477.1m)
Payments received on Loans from related parties ($40.2m) ($41.0m) ($984.6m)

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.